Aggregate-removing filter material, aggregate removal method, white blood cell-removing filter, and blood product filtering method
US-2016279549-A1 · Sep 29, 2016 · US
US10092687B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10092687-B2 |
| Application number | US-201414896632-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 9, 2014 |
| Priority date | Jun 7, 2013 |
| Publication date | Oct 9, 2018 |
| Grant date | Oct 9, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This is to provide a blood filter comprising a porous element; and a copolymer which exists in at least a part of a surface of the porous element, and which contains a recurring unit containing an organic group of the following formula (a) and a recurring unit containing an organic group of the following formula (b), wherein U a1 , U a2 , U b1 , U b2 and U b3 , and An − are as defined in the present specification and the claims.
Opening claim text (preview).
The invention claimed is: 1. A blood filter comprising a porous element and a coating that inhibits adhesion of biological substances, wherein the coating exists in at least a part of a surface of the porous element, and comprises a copolymer comprising (i) an ethylenically unsaturated monomer comprising the following formula (a) and (ii) an ethylenically unsaturated monomer comprising the following formula (b): wherein U a1 , U a2 , U b1 , U b2 and U b3 each independently represent a hydrogen atom or a linear or branched alkyl group having 1 to 5 carbon atoms, and An − represents an anion selected from the group consisting of a halide ion, an inorganic acid ion, a hydroxide ion and an isothiocyanate ion. 2. The blood filter according to claim 1 , wherein the ethylenically unsaturated monomers comprising the formulae (a) and (b) are derived from monomers of the following formulae (A) and (B), respectively: wherein T a , T b , U a1 , U a2 , U b1 , U b2 and U b3 each independently represent a hydrogen atom or a linear or branched alkyl group having 1 to 5 carbon atoms, Q a and Q b each independently represent a single bond, an ester bond or an amide bond, R a and R b each independently represent a linear or branched alkylene group having 1 to 10 carbon atoms which may be substituted by a halogen atom, An − represents an anion selected from the group consisting of a halide ion, an inorganic acid ion, a hydroxide ion and an isothiocyanate ion, and m is an integer of 0 to 6. 3. The blood filter according to claim 2 , wherein m is 1, and R a and R b each independently represent an ethylene group or a propylene group. 4. The blood filter according to claim 1 , wherein the copolymer further contains a crosslinked structure derived from a monomer of the following formula (C) or (D): wherein T c , T d and U d each independently represent a hydrogen atom or a linear or branched alkyl group having 1 to 5 carbon atoms, R c and R d each independently represent a linear or branched alkylene group having 1 to 10 carbon atoms which may be substituted by a halogen atom. 5. The blood filter according to claim 4 , wherein T c and T d each independently represent a hydrogen atom or a methyl group, U d represents a hydrogen atom, and R c and R d each independently represent an ethylene group or a propylene group. 6. The blood filter according to claim 1 , wherein the porous element is nonwoven fabric. 7. A method for manufacturing a blood filter of claim 1 , which method comprises coating a copolymer comprising (i) an ethylenically unsaturated monomer comprising the following formula (a) and (ii) an ethylenically unsaturated monomer comprising the following formula (b): wherein U a1 , U a2 , U b1 , U b2 , and U b3 each independently represent a hydrogen atom or a linear or branched alkyl group having 1 to 5 carbon atoms, and An − represents an anion selected from the group consisting of a halide ion, an inorganic acid ion, a hydroxide ion and an isothiocyanate ion onto at least a part of a surface of a porous element, and drying the coated porous element at −200° C. to 200° C. 8. The method according to claim 7 , wherein the ethylenically unsaturated monomers comprising the formulae (a) and (b) are derived from monomers of the following formulae (A) and (B), respectively: wherein T a , T b , U a1 , U a2 , U b1 , U b2 and U b3 each independently represent a hydrogen atom or a linear or branched alkyl group having 1 to 5 carbon atoms, Q a and Q b each independently represent a single bond, an ester bond or an amide bond, R a and R b each independently represent a linear or branched alkylene group having 1 to 10 carbon atoms which may be substituted by a halogen atom, An − represents an anion selected from the group consisting of a halide ion, an inorganic acid ion, a hydroxide ion and an isothiocyanate ion, and m is an integer of 0 to 6. 9. The method according to claim 7 , wherein the coating is carried out by using a varnish containing the copolymer. 10. The method according to claim 9 , wherein the varnish containing a copolymer is previously adjusted a pH. 11. The method according to claim 7 , wherein the method further comprises washing the coated porous element before and/or after the drying of the coated porous element. 12. The method according to claim 11 , wherein the washing after the drying of the coated porous element is carried out by using at least one solvent selected from the group consisting of water and an aqueous solution containing an electrolyte.
White blood cells; Leucocytes · CPC title
characterised by the presence of specified groups, e.g. introduced by chemical after-treatment · CPC title
Blood component filters, e.g. leukocyte filters · CPC title
of synthetic origin · CPC title
Polyalkenes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.